Teleflex Inc logo

Teleflex Inc (TFX)

Market Closed
13 May, 20:00
NYSE NYSE
$
126. 80
-2.44
-1.89%
$
51.5B Market Cap
- P/E Ratio
0.54% Div Yield
346,977 Volume
- Eps
$ 129.24
Previous Close
Day Range
126.33 128.87
Year Range
120.06 249.91

Summary

TFX closed today lower at $126.8, a decrease of 1.89% from yesterday's close, completing a monthly decrease of -4.61% or $6.13. Over the past 12 months, TFX stock lost -29.44%.
TFX pays dividends to its shareholders, with the most recent payment made on Mar 17, 2025. The next estimated payment will be in In 1 month on Jun 17, 2025 for a total of $0.34.
The last earnings report, released on Apr 30, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.04%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NYSE (USD).
Want to track TFX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

TFX Chart

ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX

ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX

NEW YORK CITY, NY / ACCESS Newswire / May 13, 2025 / WHY: New York, N.Y., May 13, 2025.

Accessnewswire | 3 hours ago
Teleflex Investor News: Rosen Law Firm Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX

Teleflex Investor News: Rosen Law Firm Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX

NEW YORK , May 12, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Teleflex Incorporated (NYSE: TFX) resulting from allegations that Teleflex may have issued materially misleading business information to the investing public. So What: If you purchased Teleflex securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

Prnewswire | 1 day ago
Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Shareholders to Connect

Bronstein, Gewirtz & Grossman, LLC Is Investigating Teleflex Incorporated (TFX) And Encourages Shareholders to Connect

NEW YORK CITY, NY / ACCESS Newswire / May 12, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Teleflex Incorporated ("Teleflex" or "the Company") (NYSE:TFX). Investors who purchased Teleflex securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TFX.

Accessnewswire | 1 day ago

Teleflex Inc (TFX) FAQ

What is the stock price today?

The current price is $126.80.

On which exchange is it traded?

Teleflex Inc is listed on NYSE.

What is its stock symbol?

The ticker symbol is TFX.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 51.5B.

Has Teleflex Inc ever had a stock split?

No, there has never been a stock split.

Teleflex Inc Profile

Medical Instruments & Supplies Industry
Healthcare Sector
Mr. Liam J. Kelly CEO
NYSE Exchange
US8793691069 ISIN
United States Country
14,500 Employees
7 Mar 2025 Last Dividend
17 Jun 1997 Last Split
18 Feb 1988 IPO Date

Overview

Teleflex Incorporated is a global leader in the development, manufacturing, and supply of single-use medical devices for diagnostic and therapeutic procedures in critical care and surgical applications. The company has a rich history dating back to 1943 and is headquartered in Wayne, Pennsylvania. Serving hospitals, healthcare providers, medical device manufacturers, and the home care market, Teleflex aims to improve the health and quality of life of patients worldwide with its innovative medical technologies.

Products and Services

  • Vascular Access Products: Includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems, designed for the administration of intravenous therapies, blood pressure measurement, and the withdrawal of blood samples through a single puncture site.
  • Interventional Products: Comprises a range of coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platforms. These are utilized by interventional cardiologists, radiologists, and vascular surgeons and include Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
  • Anesthesia Products: Offers airway and pain management products that support hospital, emergency medicine, and military channels, ensuring the patient's comfort and safety during medical procedures.
  • Surgical Products: Provides metal and polymer ligation clips and fascial closure surgical systems for use in laparoscopic surgeries, percutaneous surgical systems, and a range of other surgical instruments, enabling surgeons to perform with precision and efficiency.
  • Interventional Urology Products: Features the UroLift System, an innovative technology for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia, offering a minimally invasive alternative to traditional procedures.
  • Respiratory Products: Includes oxygen and aerosol therapies, spirometry, and ventilation management products for various care settings, aiding in the respiratory care of patients across a broad spectrum of care environments.
  • Urology Products: Offers a comprehensive range of catheters, urine collectors, catheterization accessories, and products for operative endourology, supporting the needs of patients with urologic conditions.
  • Bladder Management Services: Provides a suite of services and products for effective bladder management, enhancing the quality of life for patients dealing with bladder-related health issues.

Contact Information

Address: 550 East Swedesford Road
Phone: 610-225-6800